The purpose of the study is to examine lung cancer patients’ surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with the drugs that may specifically target tumors that have the genetic changes.
Learn more about the A151216 trial or call the Cancer Research Office at Pottstown Hospital (610-327-7772) or Reading Hospital (484-628-8193).
